In a new study, CHOP researchers integrate data regarding how the conditions present clinically with data on protein-protein interactions.

The FDA has approved a treatment that targets ALK mutations in relapsed, refractory ALK-positive anaplastic large cell lymphoma.

On Dec. 4-5, CHOP's Center for Pediatric Airway Disorders participated in the Society for Ear, Nose and Throat Advancement in Children (SENTAC)/Aerodigestive Society 2020 Virtual Meeting.

BE-WEHL is an in-home wellness program that includes mindfulness, deep breathing, yoga and infant or child massage education for the entire family.

CHOP researchers identified an in vivo role for activated protein C (APC), which could potentially be exploited for future hemophilia A treatments.

CHOP offers tips to help teens deal with stress and create a mindset of resilience during troubling times.

Using a novel proteomics approach, CHOP researchers have identified a host protein that restricts herpes simplex virus 1 (HSV-1) infection.

Findings suggest that risk of fractures occurring in later life could be identified in childhood and may lead to tailored interventions.

CHOP announced today it will name the emergency department in its new inpatient hospital in King of Prussia, PA after the late Madlyn K. Abramson, supported by a $2.5 million gift from The Abramson Family Foundation.

In the middle of the COVID-19 pandemic, one Virginia family chose CHOP for their daughter’s heart repair.